Iwona Baranowska

Iwona Baranowska

Auto-generated profile, based on publicly available information

Iwona Baranowska

Department of Immunology, Medical University of Warsaw, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
MKMarta Klopotowska
Marta Klopotowska
MBMalgorzata Bajor
Malgorzata Bajor
AGAgnieszka Graczyk-Jarzynka
Agnieszka Graczyk-Jarzynka
AKAgnieszka Kraft
Agnieszka Kraft
ZPZofia Pilch
Zofia Pilch
MWMagdalena Winiarska
Magdalena Winiarska
Oxidative stress, caused by the imbalance between reactive species generation and the dysfunctional capacity of antioxidant defenses, is one of the characteristic features of cancer. Here, we quantified hydrogen peroxide in the tumor microenvironment (TME) and demonstrated that hydrogen peroxide concentrations are elevated in tumor interstitial fluid isolated from murine breast cancers in vivo, when compared with blood or normal subcutaneous fluid. Therefore, we investigated the effects of increased hydrogen peroxide concentration on immune cell functions. NK cells were more susceptible to hydrogen peroxide than T cells or B cells, and by comparing T, B, and NK cells' sensitivities to redox stress and their antioxidant capacities, we identified peroxiredoxin-1 (PRDX1) as a lacking element of NK cells' antioxidative defense. We observed that priming with IL15 protected NK cells' functions in the presence of high hydrogen peroxide and simultaneously upregulated PRDX1 expression. However, the effect of IL15 on PRDX1 expression was transient and strictly dependent on the presence of the cytokine. Therefore, we genetically modified NK cells to stably overexpress PRDX1, which led to increased survival and NK cell activity in redox stress conditions. Finally, we generated PD-L1–CAR NK cells overexpressing PRDX1 that displayed potent antitumor activity against breast cancer cells under oxidative stress. These results demonstrate that hydrogen peroxide, at concentrations detected in the TME, suppresses NK cell function and that genetic modification strategies can improve CAR NK cells' resistance and potency against solid tumors.

31 March 2025 in Cancer Research
Verified
Journal Article
Open access
JDJoanna Domagala
Joanna Domagala
Tomasz M. GrzywaTomasz M. Grzywa
Tomasz M. Grzywa
IBIwona Baranowska
Iwona Baranowska
MJMagdalena Justyniarska
Magdalena Justyniarska
RTRyan Tannir
Ryan Tannir
MWMagdalena Winiarska
Magdalena Winiarska
Immunotherapy revolutionized cancer treatment in the last decade. Both NK cells and T cells are key components of host immunity against malignant cells that are being extensively investigated in the field of cancer immunotherapy. While approaches have been developed to improve the antitumor activity of NK and T cells, the tumor microenvironment remains an obstacle to effective NK and T-cell–based therapies. Here, we demonstrated that cancer-conditioned medium suppresses the antitumor activity of NK cells. Ammonia, a by-product of cancer cell metabolism, accumulated in cancer-conditioned medium and in the tumor microenvironment, and impaired the cytotoxicity of NK cells as well as the efficacy of antibody-based and chimeric antigen receptor (CAR) NK and CAR T-cell–based therapies in vitro. Ammonia induced NK and T-cell dysfunction by decreasing the amount of mature perforin in secretory lysosomes, which was dependent on its lysosomotropic features and ability to increase pH in acidic compartments. These findings demonstrate that, in addition to its previously described role in promoting tumor growth as a source of nitrogen for tumor biomass, ammonia promotes tumor immune escape by inhibiting both NK and CAR T-cell cytotoxicity. Significance: Ammonia is elevated in the tumor microenvironment and functions as an immunoinhibitory metabolite in cancer by reducing perforin levels, inhibiting NK and T-cell–mediated immunity and limiting the efficacy of immunotherapies.

1 April 2019 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
OGOlga Gawrys
Olga Gawrys
IBIwona Baranowska
Iwona Baranowska
MRMonika Rak
Monika Rak
SBSylwia Bobis-Wozowicz
Sylwia Bobis-Wozowicz
KSKarolina Szaro
Karolina Szaro
EKElżbieta Kompanowska-Jezierska
Elżbieta Kompanowska-Jezierska
Development of efficient vectors for transfection constitutes a major challenge in modern gene therapy. Viral vectors are considered more effective, but plagued by safety concerns. Research shows that derivatives of polyisoprenoid alcohols (trimethylpolyprenylammonium iodides, called PTAI), may serve as lipofectants. In previous research PTAI were proved to be effective as DNA carriers in vitro and in vivo as carriers of DNA vaccines against influenza virus. In the present study the effectiveness of two compositions (PTAI‐6–8 and PTAI‐10–14, containing a mixture of polyprenols with chain lengths from 6 to 8 subunits and from 10 to 14 subunits, respectively and helper lipids: DOPE (1,2‐dioleoyl‐sn‐glycero‐3‐phosphatidylethanolamine) and DC‐cholesterol (3β‐[N‐(N′,N′‐dimethylaminoethane)‐carbamoyl]cholesterol hydrochloride) was investigated for DNA delivery into rats' cells and compared to the commercially available reagents for transfection: in vivo‐jetPEI® (Polyplus‐transfection) and Avalanche®‐in vivo Transfection Reagent (EZ Biosystems LLC). Selected mixtures were used to enhance the expression of vascular endothelial growth factor type A (VEGF‐A) in spontaneously hypertensive rats (SHR). VEGF deficiency is considered one of the factors in the development of hypertension and related kidney diseases. In preliminary experiments, the mixtures containing lipid‐carriers and plasmid DNA (encoding reporter gene and VEGF‐A) were administered intravenously and observed for 24, 48 or 72 h, to establish the optimal conditions for transfection. Subsequently rats were anesthetized, perfused with PBS, and tissues (liver, spleen, kidney, lung) were collected for analysis. Transfection efficiency was evaluated by flow cytometry (BD FACSCanto™ II system) in single cell suspensions prepared from collected tissues. In almost all tested cell suspensions the level of fluorescence of reporter gene (eGFP or mCherry) was undetectable. Only in the liver higher expression of mCherry was observed with commercial reagents (the % of mCherry positive liver cells with Avalanche® was 42 versus 12% in control group receiving 5% glucose; p<0.05). Due to low efficiency of intravenously applied carriers, we tested if selected mixtures are able to provide stable expression of VEGF‐A gene after direct administration to the kidney. SHR were implanted with osmotic pumps (model 2001, ALZET®) connected to catheters allowing the infusion into the renal medulla. The fluorescence of mCherry in the kidneys was undetectable and there were no changes in tissue, plasma and urine levels of VEGF‐A (ELISA). Unfortunately we were not able to prove the usefulness of PTAI for transfection, however all selected mixtures, including commercially available reagents failed to deliver DNA to renal cells Support or Funding Information NCN 2015/17/N/NZ4/02831 This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

2 July 2025
Verified
Other
Open access
JDJoanna Domagala
Joanna Domagala
Tomasz M. GrzywaTomasz M. Grzywa
Tomasz M. Grzywa
IBIwona Baranowska
Iwona Baranowska
MJMagdalena Justyniarska
Magdalena Justyniarska
RTRyan Tannir
Ryan Tannir
MWMagdalena Winiarska
Magdalena Winiarska
Supplementary Fig. 9 shows that ammonia decreases acidic compartment in NK cells

2 July 2025
Verified
Other
Open access
JDJoanna Domagala
Joanna Domagala
Tomasz M. GrzywaTomasz M. Grzywa
Tomasz M. Grzywa
IBIwona Baranowska
Iwona Baranowska
MJMagdalena Justyniarska
Magdalena Justyniarska
RTRyan Tannir
Ryan Tannir
MWMagdalena Winiarska
Magdalena Winiarska
Ammonia decreases the amount of mature perforin in NK cells. A, The level of total perforin in NK cells incubated with ammonia determined by Western blot using an anti-perforin antibody (B-D48 clone; n = 3). β-Actin is presented as a loading control. Representative blot from one donor is shown. B, The concentration of extracellular perforin secreted by NK cells in response to contact with target cells (K562) in different concentrations of NH4Cl (n = 4). C, The level of perforin detected in NK cells incubated with NH4Cl determined by intracellular staining using an anti-perforin antibody (δG9 clone) and flow cytometry (n = 4). In some groups, cells were washed and incubated in a medium without NH4Cl, as indicated in the figure. MFI, mean fluorescence intensity. D, A schematic representation of perforin maturation. Green and red circles show forms of perforin recognized by B-D48 and δG9 antibodies, respectively. E, The level of perforin in NK cells incubated for 4 hours with NH4Cl determined by Western blot methods using an anti-perforin antibody (Pf-344 clone; n = 3). Two forms of perforin, immature (70 kDa) and mature (60 kDa), were detected. F, The level of perforin detected in NK cells incubated with NH4Cl determined by intracellular staining using an anti-perforin antibody (δG9 clone) and flow cytometry (n = 2). NK cells were primed with IL2 (200 U/mL) and IL15 (10 ng/mL) for 24 hours before the experiment. G, The level of perforin detected in NK cells incubated with NH4Cl and other lysosomotropic agents [chloroquine (CQ), concanamycin (CMA), and monensin] for 4 hours determined by intracellular staining using antibodies detecting total perforin (B-D48 clone) and lysosomal perforin (δG9 clone; n = 2). H, The cells were loaded with the lysosomal fluorescent probes LysoPrime Green (the pH-resistant probe) and pHLys Red (the pH-sensitive probe; Dojindo Laboratories) and treated with increasing concentrations of NH4Cl in the imaging medium or bafilomycin A as a control. Bars show calculated mean ratios of the LysoPrime Green signal divided by the pHLys Red signal (n = 3). Images show cells that were untreated (top row) and treated with 5 mmol/L NH4Cl (bottom row). Left column, staining with the pH-resistant LysoPrime Green probe (green; scale bar, 10 μm); middle column, staining with the pH-sensitive pHLys Red probe (red); right column, merge of the LysoPrime Green signal, pHLys Red signal, and transmitted light image (gray). I, pH-dependent processing of perforin by human recombinant cathepsins B and L at concentrations ranging from 1 to 100 nmol/L, analyzed by Western blot methods using an anti-perforin antibody (B-D48 clone; n = 2). J, Processing of perforin by human recombinant granzyme B at concentrations of 0.5, 1, and 2.5 μmol/L, assessed at pH 7.4 in two different buffers (n = 2). K, Raji tumor–bearing mice were intratumorally injected with 3–5 × 106 human NK cells. After 4 hours, tumors were dissected and enzymatically dissociated, followed by NK cell analysis for perforin levels using intracellular staining with an anti-perforin antibody (δG9 clone) and flow cytometry (n = 9). Human NK cells incubated with Raji cells for 4 hours in control medium in vitro were used as controls. Data show means ± SEM. The n values represent the numbers of biological replicates in in vitro experiments or the number of mice used to obtain the data. D, Created with BioRender.com. Winiarska, M. (2025) https://BioRender.com/g06z848.

2 July 2025
Verified
Other
Open access
JDJoanna Domagala
Joanna Domagala
Tomasz M. GrzywaTomasz M. Grzywa
Tomasz M. Grzywa
IBIwona Baranowska
Iwona Baranowska
MJMagdalena Justyniarska
Magdalena Justyniarska
RTRyan Tannir
Ryan Tannir
MWMagdalena Winiarska
Magdalena Winiarska
Cancer cell–conditioned medium inhibits natural cytotoxicity and ADCC of NK cells. A–D, Natural cytotoxicity of NK cells against K562 cells in the presence of control medium and lymphoma cell conditioned medium (Raji, n = 4; Daudi, n = 3; Ramos, n = 3; A), multiple myeloma cells–conditioned medium (MM.1s, n = 4; H929, n = 2; RPMI 8226, n = 3; B), breast cancer cell conditioned medium (HCC1806, n = 4; 4T1, n = 8; E0771, n = 3; EMT6, n = 3; C), and nonmalignant cell conditioned medium (L929, n = 2; T cells, n = 2; D). For A–D, K562 cells were stained with CFSE and incubated with NK cells in medium conditioned by the indicated cells. Cytotoxicity was assessed after 4 hours using flow cytometry as a percentage of propidium iodide–positive CFSE-positive (K562) cells. E, ADCC of NK cells against Raji cells with anti-CD20 antibody (100 μg/mL of RTX) and Daudi cells with anti-CD38 antibody (1 μg/mL of daratumumab, Dara) in the presence of control medium or lymphoma cell conditioned medium (n = 2). Cytotoxicity was assessed after 4 hours using flow cytometry as a percentage of propidium iodide–positive CFSE-positive cells. F, Natural cytotoxicity of NK cells against K562 cells in the presence of control medium or lymphoma cell conditioned medium (Ramos, n = 3; Raji, n = 4). The normal medium or medium lacking L-glutamine was used as control medium to generate a medium conditioned by cancer. P values were calculated using two-way ANOVA with Tukey post hoc test. Data show individual values and means ± SEM. n values are the numbers of biological replicates in in vitro experiments.